US BANCORP \DE\ - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 115 filers reported holding PULMONX CORP in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2023$1,818
-91.3%
176
-88.9%
0.00%
Q2 2023$20,792
-19.7%
1,586
-31.5%
0.00%
Q1 2023$25,893
+337.5%
2,316
+229.9%
0.00%
Q4 2022$5,918
-15.5%
702
+75.5%
0.00%
Q3 2022$7,0000.0%400
-14.2%
0.00%
Q2 2022$7,000
-30.0%
466
+23.6%
0.00%
Q1 2022$10,000
-80.4%
377
-76.3%
0.00%
Q4 2021$51,000
+37.8%
1,590
+54.4%
0.00%
Q3 2021$37,000
+68.2%
1,030
+107.7%
0.00%
Q2 2021$22,0004960.00%
Other shareholders
PULMONX CORP shareholders Q2 2023
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 815,019$37,279,00040.66%
Yu Fan 303,030$13,861,00036.18%
ABG Innovation Capital Partners III GP Ltd 833,333$38,117,00018.73%
KPCB XIII Associates, LLC 994,971$45,510,0009.36%
Iron Triangle Partners LP 600,000$27,444,0003.49%
Miura Global Management 405,000$18,525,0003.31%
GREAT POINT PARTNERS LLC 114,345$5,230,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 937,032$42,860,0000.90%
ADAMS STREET PARTNERS LLC 114,661$5,245,0000.84%
RTW INVESTMENTS, LP 1,129,600$51,668,0000.81%
View complete list of PULMONX CORP shareholders